115 related articles for article (PubMed ID: 15231655)
61. [Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol].
Bernacer M; Aracil J; Contra T; Gil C; López J; López-Ibor B; Martín N; Melero C; Valverde F; Vecilla C
An Esp Pediatr; 1988 Oct; 29 Suppl 34():68-72. PubMed ID: 3214042
[No Abstract] [Full Text] [Related]
62. Emergence of genetic instability in children treated for leukemia.
Finette BA; Homans AC; Albertini RJ
Science; 2000 Apr; 288(5465):514-7. PubMed ID: 10775110
[TBL] [Abstract][Full Text] [Related]
63. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol].
Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM
An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045
[No Abstract] [Full Text] [Related]
64. Distinct mechanisms lead to HPRT gene mutations in leukemic cells.
Lin YW; Perkins JJ; Zhang Z; Aplan PD
Genes Chromosomes Cancer; 2004 Apr; 39(4):311-23. PubMed ID: 14978792
[TBL] [Abstract][Full Text] [Related]
65. Can the genotoxicity of chemotherapy be predicted?
Pui CH; Relling MV
Lancet; 2004 Sep 11-17; 364(9438):917-8. PubMed ID: 15364174
[No Abstract] [Full Text] [Related]
66. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.
Mazur B; Olejnik I; Wylezol I; Sonta-Jakimczyk D; Szczepanski T; Karpe J
Pediatr Hematol Oncol; 2003 Jun; 20(4):303-8. PubMed ID: 12746162
[TBL] [Abstract][Full Text] [Related]
67. Measurement of mutation frequency at the HPRT locus in peripheral lymphocytes. Is this a good method to evaluate a cancer risk in pediatric patients?
Lin YW; Kubota M; Akiyama Y; Sawada M; Furusho K
Adv Exp Med Biol; 1998; 431():681-6. PubMed ID: 9598152
[TBL] [Abstract][Full Text] [Related]
68. Long-term effects of antineoplastic chemotherapy and radiotherapy on dental development.
Maguire A; Welbury RR
Dent Update; 1996 Jun; 23(5):188-94. PubMed ID: 8948180
[TBL] [Abstract][Full Text] [Related]
69. [Long term results of treatment with cytostatic drugs on respiratory function tests in children].
Koehler M; Brewczyński P; Bubała H; Białkowski J; Bogusz J; Wieczorek M
Pneumonol Pol; 1990; 58(7-8):374-7. PubMed ID: 8614663
[TBL] [Abstract][Full Text] [Related]
70. Accumulation of somatic mutations in proliferating T cell clones from children treated for leukemia.
Finette BA; Homans AC; Rivers J; Messier T; Albertini RJ
Leukemia; 2001 Dec; 15(12):1898-905. PubMed ID: 11753611
[TBL] [Abstract][Full Text] [Related]
71. Atypical background somatic mutant frequencies at the HPRT locus in children and adults with Down syndrome.
Finette BA; Rood B; Poseno T; Vacek P; Pueschel S; Homans AC
Mutat Res; 1998 Jul; 403(1-2):35-43. PubMed ID: 9726004
[TBL] [Abstract][Full Text] [Related]
72. [Neurologic tests in children having recovered from leukemia].
Schuler D; Bakos M; Kardos G; Koós R; Révész T; Somló P; Nagy C; Gacsályi I; Kálmánchey R
Orv Hetil; 1989 Jul; 130(31):1639-41. PubMed ID: 2771396
[TBL] [Abstract][Full Text] [Related]
73. Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia.
Lennard L; Hale JP; Lilleyman JS
Br J Clin Pharmacol; 1993 Oct; 36(4):277-84. PubMed ID: 12959304
[TBL] [Abstract][Full Text] [Related]
74. [Late effects after treatment of childhood leukemia. The Danish Society of Pediatrics].
Nysom K
Ugeskr Laeger; 2002 Mar; 164(12):1651. PubMed ID: 11924274
[No Abstract] [Full Text] [Related]
75. Somatic cell mutation in pediatric patients undergoing allogeneic bone marrow transplantation.
Hamahata K; Kubota M; Usami I; Lin YW; Shimizu K; Morimoto A; Nakahata T
Mutat Res; 2002 May; 517(1-2):21-8. PubMed ID: 12034305
[TBL] [Abstract][Full Text] [Related]
76. Mutational spectral analysis at the HPRT locus in healthy children.
Finette BA; Kendall H; Vacek PM
Mutat Res; 2002 Aug; 505(1-2):27-41. PubMed ID: 12175903
[TBL] [Abstract][Full Text] [Related]
77. Acute lymphocytic leukemia in children. A medical success story.
Kelly KP
Adv Nurse Pract; 2000 Apr; 8(4):57-8, 61-4, 94. PubMed ID: 11146951
[No Abstract] [Full Text] [Related]
78. Clinical nanomedicine: a solution to the chemotherapy conundrum in pediatric leukemia therapy.
Krishnan V; Rajasekaran AK
Clin Pharmacol Ther; 2014 Feb; 95(2):168-78. PubMed ID: 24013811
[TBL] [Abstract][Full Text] [Related]
79. Chemotherapy-related side effects in children with acute lymphocytic leukemia in Taiwan: a nursing perspective.
Chen YC; Lin KH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(2):119-29. PubMed ID: 1514401
[TBL] [Abstract][Full Text] [Related]
80. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
Cheok MH; Evans WE
Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
